TipRanks
Zevra Therapeutics (DE:1GDA)
FRANKFURT:1GDA
Germany Market
1GDA
Zevra Therapeutics
RESEARCH TOOLSreports

Zevra Therapeutics (1GDA) Balance Sheet

1 Followers

Zevra Therapeutics Balance Sheet

Zevra Therapeutics's total assets for Q2 2026 were $302.71M, an increase of 8.66% from the previous quarter. DE:1GDA total liabilities were $85.06M for the fiscal quarter, a 16.88% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 284.73M$ 178.13M$ 172.33M$ 115.34M$ 132.94M
Total Liabilities
$ 130.07M$ 138.46M$ 110.46M$ 40.22M$ 5.82M
Total Equity Gross Minority
$ 154.66M$ 39.67M$ 61.86M$ 75.12M$ 127.12M
Other Metrics
Currency in USD

Zevra Therapeutics Debt to Assets